Clinical implications of serum <i>N‐</i>glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumorsTakuma Narita, Chikara Οhyama, Shingo Hatakeyama et al.|Cancer Medicine|2017Cited by 26
A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective AgonistAkinori Morita, Toshiya Inaba, Keiji Tanimoto et al.|Molecular Cancer Therapeutics|2017Cited by 19
AS-2, a novel inhibitor of p53-dependent apoptosis, prevents apoptotic mitochondrial dysfunction in a transcription-independent manner and protects mice from a lethal dose of ionizing radiationAkinori Morita, Shin Aoki, Shinya Ariyasu et al.|Biochemical and Biophysical Research Communications|2014Cited by 17
Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005–2009 and a comparison with those treated in 1985–2004Yuta Shibamoto, Kazunori Suzuki, Minako Sumi et al.|International Journal of Clinical Oncology|2013Cited by 8
PD53-08 CLINICAL IMPLICATIONS OF SERUM <i>N</i> -GLYCAN PROFILING AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN GERM-CELL TUMORSTakuma Narita, Chikara Οhyama, Shingo Hatakeyama et al.|The Journal of Urology|2017Cited by 0